ID
IMPV

Integral Derivatives’s Imperva, Inc. IMPV Stock Holding History

Integral Derivatives’s Portfolio IMPV Stock Details IMPV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-5,950
Closed -$294K – 1510
2014
Q4 		$294K Sell
5,950
-1,300
-18% -$52K 0.01% 1086
2014
Q3 		$208K Buy
+7,250
New +$197K ﹤0.01% 1272

Other funds holding IMPV

EC
Eminence Capital New York $4.36B AUM 3.1% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EM
Elliott Management New York $11.8B AUM 20.29% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return
RC
RGM Capital Naples, Florida $2.06B AUM 8.49% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
EMG
ETF Managers Group Summit, New Jersey $3.1B AUM 17.12% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return

Integral Derivatives's IMPV Position: Q1 2015 in Review

Integral Derivatives sold out of Imperva, Inc. (IMPV) in Q1 2015, closing a stake of 5,950 shares — an estimated $294K sold.

Integral Derivatives first reported a position in IMPV in Q3 2014 and held it in 2 quarters. The position peaked at $294K in Q4 2014. 146 funds tracked by Wall St. Rank hold IMPV as of Q1 2015.

  • Integral Derivatives reported no remaining Imperva, Inc. position as of Q1 2015 after selling out during the quarter.
  • Integral Derivatives sold 5,950 Imperva, Inc. shares in Q1 2015, an estimated $294K.
  • Integral Derivatives first reported a position in Imperva, Inc. in Q3 2014 and held it in 2 quarters.
  • Integral Derivatives's Imperva, Inc. position peaked at $294K in Q4 2014.
  • 146 funds tracked by Wall St. Rank held Imperva, Inc. as of Q1 2015.

Based on Integral Derivatives's 13F filing for Q1 2015, filed 20 Apr 2015.